Equity Pulse and IBD
Equity Pulse's Vision for Bridging IBD and Healthcare Disparities.
Innovation
- At the heartbeat of EquityPulse lies a groundbreaking vision. To revolutionize healthcare through social media utilizing accessibility and education keenly focused on communities of color. Our campaign is meticulously crafted to address healthcare disparities, blending innovation with evidence-based strategies from a comprehensive literature review of IBD and successful disease focus social media awareness campaigns.
we’re here to answer your questions
“Our goal is to meet IBD patients where they are and create a dialogue between the people who want to help them.”
Distinctive Features of EquityPulse
Narrative-Driven Approach: EquityPulse harnesses the power of personal stories. Through our health advocates which we call PulsePower Advocates, we share compelling narratives on social media, creating a resonant and relatable platform and community. These narratives include patients who triumph over IBD, physicians and scientists who made strides improving IBD treatment and education, as well as leaders and organizations who work with IBD patients with communities of color.
Holistic Engagement Strategy
Our campaign is not just about outreach; it’s about meaningful engagement. We’ve sculpted diverse roles, from Heartbeat Ambassadors to PolicyPulse Change Composers, each designed to address unique facets of healthcare disparities. Our campaign utilizes community members for support and panelists to educate our social media engagers. This ensures a multi-dimensional and comprehensive approach to our mission.
Digital Prowess
In today’s digital age, the impact of social media is undeniable. EquityPulse is poised to maximize this potential.
It builds on the findings of these which found that focusing on evaluating the quality of IBD-related information available on social media platforms coupled with focusing on the efficacy of using social media for IBD patient education and support needed to be explored. By using surveys we can better understand underserved populations of IDB patients’ attitudes, thoughts, feelings, knowledge, toward clinical trials improving access and understanding of IDB within these communities.